Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Presentation
May 15, 2018

Protein Therapeutics by Immunoaffinity LC-MS: Latest Trends and Recommendations

Learn about the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics
Significant developments have impacted the application of immunoaffinity liquid chromatography-mass spectrometry (LC-MS) to regulated biotherapeutics. This presentation focuses on the latest LC-MS technologies and techniques that are impacting the development of protein-based drugs. Approaches taken are in line with industry trends and regulatory expectations established around bioanalysis.

What will you learn?
  • The strengths and weaknesses of LC-MS for protein bioanalysis
  • How to apply modern LC-MS technology, including nano-flow LC and high resolution mass spectrometry (HRMS)
  • Principles around holistic bioanalytical strategies for biotherapeutics

Authors:
Stephen Lowes, Ph.D., Senior Scientific Director, Bioanalysis and ADME Services
Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers

Related Services:
Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Read More